Radcliffe Capital Management, L.P. - EPIPHANY TECHNOLOGY ACQUISIT ownership

EPIPHANY TECHNOLOGY ACQUISIT's ticker is EPHY and the CUSIP is 29429X109. A total of 92 filers reported holding EPIPHANY TECHNOLOGY ACQUISIT in Q1 2022. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
Radcliffe Capital Management, L.P. ownership history of EPIPHANY TECHNOLOGY ACQUISIT
ValueSharesWeighting
Q3 2022$6,907,000
+2.4%
699,093
+1.7%
0.17%
+7.7%
Q2 2022$6,748,000
+3.2%
687,157
+3.2%
0.16%
+4.0%
Q1 2022$6,536,000
+11.6%
665,568
+10.9%
0.15%
-2.6%
Q4 2021$5,856,000
-0.1%
600,0000.0%0.15%
-10.5%
Q3 2021$5,862,000
+0.4%
600,0000.0%0.17%
-6.6%
Q2 2021$5,838,000
-0.6%
600,0000.0%0.18%
-21.8%
Q1 2021$5,874,000600,0000.23%
Other shareholders
EPIPHANY TECHNOLOGY ACQUISIT shareholders Q1 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of EPIPHANY TECHNOLOGY ACQUISIT shareholders